Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10681 | 1042 | 52.9 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
385 | 3 | MICROGLIA//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM | 31368 |
903 | 2 | MICROGLIA//BRAIN BEHAVIOR AND IMMUNITY//CYTOKINES | 11265 |
10681 | 1 | CYCLOOXYGENASE//NEUROINFLAMMAT S//BUTAPROST | 1042 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE | authKW | 140320 | 12% | 4% | 129 |
2 | NEUROINFLAMMAT S | address | 137545 | 1% | 36% | 13 |
3 | BUTAPROST | authKW | 68364 | 1% | 33% | 7 |
4 | CYCLOOXYGENASE 2 | authKW | 66486 | 9% | 3% | 89 |
5 | BUDESONIDE EPIMER R | authKW | 58606 | 0% | 100% | 2 |
6 | C 11KETOPROFEN METHYL ESTER | authKW | 58606 | 0% | 100% | 2 |
7 | CYCLOOXGENASES | authKW | 58606 | 0% | 100% | 2 |
8 | EP2 | authKW | 57783 | 1% | 16% | 12 |
9 | MOL NEUROSCI UNIT | address | 53570 | 1% | 23% | 8 |
10 | PROSTAGLANDINS | authKW | 50879 | 11% | 2% | 114 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 9071 | 54% | 0% | 562 |
2 | Clinical Neurology | 1544 | 18% | 0% | 186 |
3 | Geriatrics & Gerontology | 1340 | 6% | 0% | 66 |
4 | Pharmacology & Pharmacy | 669 | 17% | 0% | 176 |
5 | Biochemistry & Molecular Biology | 127 | 14% | 0% | 143 |
6 | Pathology | 114 | 4% | 0% | 38 |
7 | Gerontology | 73 | 1% | 0% | 13 |
8 | Immunology | 50 | 5% | 0% | 55 |
9 | Psychiatry | 50 | 4% | 0% | 38 |
10 | Medicine, Research & Experimental | 28 | 3% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROINFLAMMAT S | 137545 | 1% | 36% | 13 |
2 | MOL NEUROSCI UNIT | 53570 | 1% | 23% | 8 |
3 | BRAIN PHYSIOL METAB SECT | 45958 | 2% | 8% | 19 |
4 | CIEB IFAL | 39069 | 0% | 67% | 2 |
5 | TRANSLAT MED OPHTHALMOL | 39069 | 0% | 67% | 2 |
6 | ACRAF SPA ANGELINI | 29303 | 0% | 100% | 1 |
7 | AMGEN SOUTH SAN FRANCISCO | 29303 | 0% | 100% | 1 |
8 | BIOMED BARCELONA INVEST BIOMED AUGU | 29303 | 0% | 100% | 1 |
9 | BRAIN I EMIA NEURODEGENERATCSIC | 29303 | 0% | 100% | 1 |
10 | CLIN NEUROSCICLIN EXPT SCI UNIT | 29303 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROINFLAMMATION | 6289 | 2% | 1% | 19 |
2 | NEUROBIOLOGY OF AGING | 2660 | 2% | 0% | 23 |
3 | ALZHEIMERS & DEMENTIA | 2206 | 1% | 1% | 8 |
4 | NEUROBIOLOGY OF DISEASE | 2024 | 2% | 0% | 16 |
5 | JOURNAL OF NEUROCHEMISTRY | 1979 | 4% | 0% | 38 |
6 | JOURNAL OF NEUROIMMUNOLOGY | 1542 | 2% | 0% | 19 |
7 | JOURNAL OF ALZHEIMERS DISEASE | 1433 | 1% | 0% | 15 |
8 | BRAIN RESEARCH | 1418 | 5% | 0% | 49 |
9 | JOURNAL OF NEUROSCIENCE RESEARCH | 1306 | 2% | 0% | 20 |
10 | NEUROCHEMISTRY INTERNATIONAL | 1214 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE | 140320 | 12% | 4% | 129 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
2 | BUTAPROST | 68364 | 1% | 33% | 7 | Search BUTAPROST | Search BUTAPROST |
3 | CYCLOOXYGENASE 2 | 66486 | 9% | 3% | 89 | Search CYCLOOXYGENASE+2 | Search CYCLOOXYGENASE+2 |
4 | BUDESONIDE EPIMER R | 58606 | 0% | 100% | 2 | Search BUDESONIDE+EPIMER+R | Search BUDESONIDE+EPIMER+R |
5 | C 11KETOPROFEN METHYL ESTER | 58606 | 0% | 100% | 2 | Search C+11KETOPROFEN+METHYL+ESTER | Search C+11KETOPROFEN+METHYL+ESTER |
6 | CYCLOOXGENASES | 58606 | 0% | 100% | 2 | Search CYCLOOXGENASES | Search CYCLOOXGENASES |
7 | EP2 | 57783 | 1% | 16% | 12 | Search EP2 | Search EP2 |
8 | PROSTAGLANDINS | 50879 | 11% | 2% | 114 | Search PROSTAGLANDINS | Search PROSTAGLANDINS |
9 | NEUROINFLAMMATION | 48172 | 8% | 2% | 81 | Search NEUROINFLAMMATION | Search NEUROINFLAMMATION |
10 | ANIMAL MODEL OF ALZHEIMERS DISEASE | 39069 | 0% | 67% | 2 | Search ANIMAL+MODEL+OF+ALZHEIMERS+DISEASE | Search ANIMAL+MODEL+OF+ALZHEIMERS+DISEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CANDELARIO-JALIL, E , FIEBICH, BL , (2008) CYCLOOXYGENASE INHIBITION IN ISCHEMIC BRAIN INJURY.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 14. P. 1401-1418 | 136 | 47% | 49 |
2 | MCGEER, PL , MCGEER, EG , (2007) NSAIDS AND ALZHEIMER DISEASE: EPIDEMIOLOGICAL, ANIMAL MODEL AND CLINICAL STUDIES.NEUROBIOLOGY OF AGING. VOL. 28. ISSUE 5. P. 639-647 | 45 | 69% | 259 |
3 | CUDABACK, E , JORSTAD, NL , YANG, Y , MONTINE, TJ , KEENE, CD , (2014) THERAPEUTIC IMPLICATIONS OF THE PROSTAGLANDIN PATHWAY IN ALZHEIMER'S DISEASE.BIOCHEMICAL PHARMACOLOGY. VOL. 88. ISSUE 4. P. 565-572 | 56 | 48% | 20 |
4 | ROJAS, A , JIANG, JX , GANESH, T , YANG, MS , LELUTIU, N , GUEORGUIEVA, P , DINGLEDINE, R , (2014) CYCLOOXYGENASE-2 IN EPILEPSY.EPILEPSIA. VOL. 55. ISSUE 1. P. 17-25 | 41 | 59% | 26 |
5 | IMBIMBO, BP , (2009) AN UPDATE ON THE EFFICACY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN ALZHEIMER'S DISEASE.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 18. ISSUE 8. P. 1147-1168 | 52 | 51% | 49 |
6 | WOODLING, NS , ANDREASSON, KI , (2016) UNTANGLING THE WEB: TOXIC AND PROTECTIVE EFFECTS OF NEUROINFLAMMATION AND PGE(2) SIGNALING IN ALZHEIMER'S DISEASE.ACS CHEMICAL NEUROSCIENCE. VOL. 7. ISSUE 4. P. 454 -463 | 45 | 49% | 2 |
7 | HOOZEMANS, JJM , ROZEMULLER, JM , VAN HAASTERT, ES , VEERHUIS, R , EIKELENBOOM, P , (2008) CYCLOOXYGENASE-1 AND-2 IN THE DIFFERENT STAGES OF ALZHEIMER'S DISEASE PATHOLOGY.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 14. P. 1419-1427 | 52 | 50% | 67 |
8 | HOOZEMANS, JJM , VEERHUIS, R , ROZEMULLER, JM , EIKELENBOOM, P , (2011) SOOTHING THE INFLAMED BRAIN: EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON ALZHEIMER'S DISEASE PATHOLOGY.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 10. ISSUE 1. P. 57-67 | 55 | 47% | 21 |
9 | CHAUDHRY, U , ZHUANG, H , DORE, S , (2010) MICROSOMAL PROSTAGLANDIN E SYNTHASE-2: CELLULAR DISTRIBUTION AND EXPRESSION IN ALZHEIMER'S DISEASE.EXPERIMENTAL NEUROLOGY. VOL. 223. ISSUE 2. P. 359-365 | 37 | 74% | 13 |
10 | GROSSBERG, GT , DEARDORFF, WJ , (2017) TARGETING NEUROINFLAMMATION IN ALZHEIMER'S DISEASE: EVIDENCE FOR NSAIDS AND NOVEL THERAPEUTICS.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 17. ISSUE 1. P. 17 -32 | 41 | 36% | 1 |
Classes with closest relation at Level 1 |